Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | K252a |
Synonyms | |
Therapy Description |
K-252a is an ATP-competitive inhibitor of cyclic nucleotide-dependent protein kinases and protein kinase C, and also has inhibitory activity against TRKs and MET, potentially resulting in decreased downstream signaling and reduced tumor cell proliferation (PMID: 3028414, PMID: 12118367). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
K252a | K252-a|K252 a|K-252a | MET Inhibitor 59 PKC Inhibitor (Pan) 11 Trk Receptor Inhibitor (Pan) 32 | K-252a is an ATP-competitive inhibitor of cyclic nucleotide-dependent protein kinases and protein kinase C, and also has inhibitory activity against TRKs and MET, potentially resulting in decreased downstream signaling and reduced tumor cell proliferation (PMID: 3028414, PMID: 12118367). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|